| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,043 |
2,533 |
$115K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
733 |
637 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
113 |
102 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
40 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
51 |
45 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
103 |
84 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
18 |
12 |
$33.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
13 |
$7.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
32 |
27 |
$3.68 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
361 |
303 |
$1.78 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
16 |
15 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
223 |
188 |
$0.00 |